Mutagenesis and mechanism-based inhibition of Streptococcus pyogenes Glu-tRNAGln amidotransferase implicate a serine-based glutaminase site.
The absence of Gln-tRNA synthetase in certain bacteria necessitates an alternate pathway for the production of Gln-tRNA(Gln): misacylated Glu-tRNA(Gln) is transamidated by a Gln-dependent amidotransferase (Glu-AdT) via catalysis of Gln hydrolysis, ATP hydrolysis, activation of Glu-tRNA(Gln), and aminolysis of activated tRNA by Gln-derived NH(3). As observed for other Gln-coupled amidotransferases, substrate binding, Gln hydrolysis, and transamidation by Glu-AdT are tightly coordinated [Horiuchi, K. Y., Harpel, M. R., Shen, L., Luo, Y., Rogers, K. C., and Copeland, R. A. (2001) Biochemistry 40, 6450-6457]. However, Glu-AdT does not employ an active-site Cys nucleophile for Gln hydrolysis, as is common in all other glutaminases: some Glu-AdT lack Cys, but all contain a conserved Ser (Ser176 in the A subunit of Streptococcus pyogenes Glu-AdT) within a sequence signature motif of Ser-based amidases. Our current results with S. pyogenes Glu-AdT support this characterization of Glu-AdT as a Ser-based glutaminase. Slow-onset (approximately 50 M(-1) s(-1)), tight-binding (t(1/2) > 2.5 h for complex dissociation), Gln-competitive inhibition of the Glu-tRNA(Gln)/ATP-independent glutaminase activity of Glu-AdT by gamma-Glu boronic acid is consistent with engagement of a Ser nucleophile in the glutaminase active site. Conversion to rapidly reversible, yet still potent (K(i) = 73 nM) and Gln-competitive, inhibition under full transamidation conditions mirrors the coupling between Gln hydrolysis and aminolysis reactions during productive transamidation. Site-directed replacement of Ser176 by Ala abolishes glutaminase and Gln-dependent transamidase activities of Glu-AdT (>300-fold), but retains a wild-type level of NH(3)-dependent transamidation activity. These results demonstrate the essentiality of Ser176 for Gln hydrolysis, provide additional support for coordinated coupling of Gln hydrolysis and transamidase transition states during catalysis, and validate glutaminase-directed inhibition of Glu-AdT as a route for antimicrobial chemotherapy.
Harpel
Mark R
MR
Chemical Enzymology Department, Bristol-Myers Squibb Company, Experimental Station, Route 141 and Henry Clay Road, Wilmington, Delaware 19880, USA. mark.harpel@bms.com
Horiuchi
Kurumi Y
KY
Luo
Ying
Y
Shen
Li
L
Jiang
Wenjun
W
Nelson
David J
DJ
Rogers
Kelley C
KC
Decicco
Carl P
CP
Copeland
Robert A
RA
D000409:Alanine / Q000235:genetics; D000577:Amides / Q000037:antagonists & inhibitors / Q000378:metabolism; D000595:Amino Acid Sequence; D019881:Aminoacyltransferases / Q000737:chemistry; D001665:Binding Sites / Q000235:genetics; D001667:Binding, Competitive / Q000235:genetics; D001897:Boronic Acids / Q000037:antagonists & inhibitors / Q000737:chemistry; D017124:Conserved Sequence; D005972:Glutaminase / Q000737:chemistry*; D005973:Glutamine / Q000037:antagonists & inhibitors / Q000378:metabolism; D006868:Hydrolysis / Q000187:drug effects; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D019884:Nitrogenous Group Transferases / Q000037:antagonists & inhibitors* / Q000235:genetics* / Q000378:metabolism; D012694:Serine / Q000737:chemistry* / Q000235:genetics; D013297:Streptococcus pyogenes / Q000201:enzymology* / Q000235:genetics*
D000577:Amides; D001897:Boronic Acids; D005973:Glutamine; D012694:Serine; D019881:Aminoacyltransferases; C023175:transamidases; D019884:Nitrogenous Group Transferases; C047694:glutamyl-tRNA(Gln) amidotransferase; D005972:Glutaminase; D000409:Alanine